In trading on Friday, shares of BioMarin Pharmaceutical Inc. (NASD: BMRN) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $86.77 per share.
In trading on Friday, shares of BioMarin Pharmaceutical Inc. (NASD: BMRN) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $86.77 per share.